Clinical Trials Directory

Trials / Completed

CompletedNCT01574781

Non-invasive Prenatal Diagnostic Validation Study

Development of Non-invasive Prenatal Diagnostic Test Based on Fetal DNA Isolated From Maternal Blood

Status
Completed
Phase
Study type
Observational
Enrollment
1,781 (actual)
Sponsor
Natera, Inc. · Industry
Sex
All
Age
18 Years
Healthy volunteers
Accepted

Summary

The primary purpose of this study is to collect maternal blood samples from pregnant women to develop a non-invasive prenatal diagnostic test based on fetal DNA isolated from maternal blood.

Detailed description

The investigators will seek to enroll subjects to collect the following types of samples: * Up to 2,000 maternal blood samples along with their corresponding paternal blood, buccal or saliva samples (1,000 required for final analysis). * Up to 200 maternal blood samples from carrying a fetus with a confirmed chromosomal abnormality or genetic disorder, along with their corresponding paternal blood, buccal or saliva samples (50 required for final analysis). For women who opted for termination, a genetic sample of the fetus may also be collected. * Up to 1,000 buccal or saliva samples from paternal grandfathers and/or the biological father's brothers. * Up to 1,000 cord, buccal or saliva samples from the born children. * Up to 40 blood samples (20 non-pregnant females and 20 males) from healthy volunteers (20 required for final analysis) * Up to 400 blood samples from women undergoing D\&C procedure following a miscarriage along with corresponding paternal blood (or buccal or saliva samples) (200 required for final analysis).

Conditions

Interventions

TypeNameDescription
PROCEDUREBlood drawBlood is drawn at the appropriate time given their cohort inclusion.
PROCEDURECheek swab/Saliva SamplingIn lieu of blood draw, male relatives may donate cheek swab or saliva sample. Children born to participating women can donate cheek swab or saliva sample soon after birth.

Timeline

Start date
2011-09-01
Primary completion
2013-04-01
Completion
2013-04-01
First posted
2012-04-10
Last updated
2013-07-02

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT01574781. Inclusion in this directory is not an endorsement.